INdians Followed for INtensive Lipid Lowering Treatment and Its safetY

NCT00664469 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

64

Enrollment

OTHER

Sponsor class

Stopped Poor enrollment

Conditions

Hypercholesterolemia

Interventions

DRUG: ezetimibe
DRUG: Comparator: Simvastatin 20, 40 and 80 mg
DRUG: Comparator: Atorvastatin
DRUG: Comparator: Rosuvastatin

Sponsor

Sunnybrook Health Sciences Centre

Collaborators

[object Object]
[object Object]